Free Trial

VectivBio (VECT) Institutional Ownership

VectivBio logo
$16.85 0.00 (0.00%)
(As of 11/20/2024 ET)

Institutional Ownership Changes (13F Filings) for VectivBio (NASDAQ:VECT)

Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$8.09M
Number of
Institutional Sellers
(last 12 months)
0
Get VECT Insider Trade Alerts

Want to know when executives and insiders are buying or selling VectivBio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

VECT Institutional Buying and Selling by Quarter

VectivBio Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
1/23/2024 Regency Capital Management Inc. DE510,000$8.59M5.5%+1,600.0%0.000%
8/22/2023CHI Advisors LLC2,782,756$46.95M14.2%-47.1%0.000%
8/14/2023Ergoteles LLC443,928$7.49M0.4%N/A0.000%
8/14/2023 EHP Funds Inc.170,000$2.87M0.7%N/A0.000%
8/14/2023 Hunting Hill Global Capital LLC63,581$1.07M0.3%N/A0.000%
8/14/2023 Prelude Capital Management LLC219,643$3.71M0.2%N/A0.000%
8/14/2023 Chicago Capital Management LLC173,840$2.96M3.8%N/A0.000%
8/11/2023 Hsbc Holdings PLC562,022$9.48M0.0%N/A0.000%
8/10/2023 Gardner Lewis Asset Management L P642,769$10.84M3.9%N/A1.889%
8/10/2023 Alpine Associates Management Inc.1,806,697$30.71M1.4%N/A5.311%
8/7/2023 Wolverine Asset Management LLC33,426$564K0.0%N/A0.000%
8/7/2023 Versor Investments LP1,210,379$20.42M3.5%N/A0.000%
8/7/2023 New York Life Investment Management LLC135,051$2.28M0.0%N/A0.000%
8/3/2023 Picton Mahoney Asset Management100,000$1.70M0.1%N/A0.000%
8/1/2023 Regency Capital Management Inc. DE30,000$506K0.4%-21.1%0.000%
7/27/2023Virtu Financial LLC41,411$699K0.1%N/A0.000%
7/27/2023 GAM Holding AG27,545$465K0.0%N/A0.000%
7/20/2023 Harvest Management LLC45,817$779K0.7%N/A0.135%
7/20/2023 Exchange Traded Concepts LLC8,512$144K0.0%N/A0.000%
5/11/2023CHI Advisors LLC5,255,484$44.72M11.9%-4.3%0.000%
5/10/2023Tekla Capital Management LLC682,834$5.87M0.2%-7.4%0.000%
5/8/2023 Regency Capital Management Inc. DE38,000$323K0.4%N/A0.000%
2/14/2023 VR Adviser LLC1,866,000$16.17M2.6%N/A5.487%
2/14/2023 Driehaus Capital Management LLC1,716,656$14.78M0.2%+100.8%5.048%
2/13/2023 Vivo Capital LLC2,333,300$20.22M2.3%N/A6.861%
2/10/2023Tekla Capital Management LLC737,704$6.35M0.2%-2.5%2.169%
2/8/2023 UBS Group AG253,877$2.20M0.0%-2.4%0.746%
2/3/2023 Frazier Life Sciences Management L.P.1,333,400$11.48M0.7%N/A3.920%
11/15/2022 Citadel Advisors LLC3,145,251$18.87M0.0%+0.1%9.248%
11/14/2022 Cormorant Asset Management LP2,536,617$15.22M1.1%-10.7%7.457%
11/14/2022 Caxton Corp140,863$845K1.6%-27.6%0.414%
11/3/2022 Barclays PLC7,807$47K0.0%N/A0.023%
10/13/2022 National Bank of Canada FI165,333$992K0.0%N/A0.486%
8/16/2022 Driehaus Capital Management LLC865,229$4.67M0.1%+120.0%2.544%
8/15/2022 Caxton Corp194,577$1.05M1.4%N/A0.572%
2/3/2022 Canaan Partners XI LLC37,051$182K0.0%N/A0.109%
11/16/2021CHI Advisors LLC2,592,602$20.03M5.8%+0.3%7.622%
11/16/2021 Citadel Advisors LLC2,721,363$20.73M0.0%-0.2%8.000%
11/15/2021 Caas Capital Management LP22,565$174K0.0%-45.1%0.066%
8/17/2021 Woodline Partners LP86,596$1.01M0.0%N/A0.255%
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)

As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.

👉 Click here to access your FREE report now!
8/17/2021 Millennium Management LLC95,214$1.11M0.0%N/A0.280%
8/17/2021 PFM Health Sciences LP611,074$7.13M0.2%N/A1.796%
8/17/2021 Caas Capital Management LP41,096$479K0.0%N/A0.121%
8/17/2021 Citadel Advisors LLC2,725,767$31.24M0.0%N/A8.013%
8/16/2021 Squarepoint Ops LLC25,000$292K0.0%N/A0.073%
8/16/2021Pinz Capital Management LP30,561$356K0.1%N/A0.090%
8/13/2021 Northern Trust Corp7,159$83K0.0%N/A0.021%
8/13/2021Tekla Capital Management LLC145,000$1.69M0.1%N/A0.426%
8/13/2021 Geode Capital Management LLC17,780$207K0.0%N/A0.052%
8/12/2021 Monashee Investment Management LLC54,466$635K0.1%N/A0.160%
8/11/2021CHI Advisors LLC2,585,986$30.15M7.0%N/A7.602%
(Data available from 1/1/2016 forward)

VECT Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of VECT shares?

During the previous two years, 24 institutional investors and hedge funds held shares of VectivBio. The most heavily invested institutionals were CHI Advisors LLC ($46.95M), Alpine Associates Management Inc. ($30.71M), Versor Investments LP ($20.42M), Vivo Capital LLC ($20.22M), VR Adviser LLC ($16.17M), Driehaus Capital Management LLC ($14.78M), and Frazier Life Sciences Management L.P. ($11.48M).Learn more on VECT's institutional investors.

Which institutional investors have been buying VectivBio stock?

Of the 21 institutional investors that purchased VectivBio stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vivo Capital LLC ($2.33M), VR Adviser LLC ($1.87M), Alpine Associates Management Inc. ($1.81M), Frazier Life Sciences Management L.P. ($1.33M), Versor Investments LP ($1.21M), Driehaus Capital Management LLC ($861.92K), and Gardner Lewis Asset Management L P ($642.77K).

How much institutional buying is happening at VectivBio?

Institutional investors have bought a total of 12,597,242 shares in the last 24 months. This purchase volume represents approximately $159.72M in transactions.

Which VectivBio major shareholders have been selling company stock?

The following institutional investors have sold VectivBio stock in the last 24 months: CHI Advisors LLC ($2.71M), Tekla Capital Management LLC ($73.67K), Regency Capital Management Inc. DE ($8K), and UBS Group AG ($6.29K).

How much institutional selling is happening at VectivBio?

Institutional investors have sold a total of 2,798,095 shares in the last 24 months. This volume of shares sold represents approximately $44.55M in transactions.



This page (NASDAQ:VECT) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners